E-Therapeutics PLC ETPPF:Grey Market

RT Quote | Exchange | USD
Last | 12/16/20 EST
0.23UNCH (UNCH)
52 week range
0.16 - 0.23

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.23
  • 52 Week High0.23
  • 52 Week High Date12/16/20
  • 52 Week Low0.16
  • 52 Week Low Date07/08/20
  • Market Cap139.69M
  • Shares Out419.06M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-18.42
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest E-Therapeutics PLC News

There is no recent news for this security.

Latest ETPPF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
e-Therapeutics Plc is a United Kingdom-based company, which provides computer-based drug discovery platform. The Company uses its Network-Driven Drug Discovery (NDD) platform to develop intellectual property protected and pre-clinical drug discovery programs. The Company utilizes its biological proficiency and computer-based platform to create and analyze network models of disease processes to identify patterns of proteins. NDD enables network analysis, data mining, machine...
Ali Mortazavi
Chairman
Address
17 Blenheim Office Park
Witney
OX29 8LN
United Kingdom